Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to -$11.8 million.

  • Orthopediatrics' Profit After Tax fell 4866.78% to -$11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$45.6 million, marking a year-over-year decrease of 6036.42%. This contributed to the annual value of -$37.8 million for FY2024, which is 8032.8% down from last year.
  • Orthopediatrics' Profit After Tax amounted to -$11.8 million in Q3 2025, which was down 4866.78% from -$7.1 million recorded in Q2 2025.
  • In the past 5 years, Orthopediatrics' Profit After Tax registered a high of $18.5 million during Q3 2022, and its lowest value of -$16.1 million during Q4 2024.
  • Moreover, its 5-year median value for Profit After Tax was -$6.8 million (2023), whereas its average is -$5.4 million.
  • Within the past 5 years, the most significant YoY rise in Orthopediatrics' Profit After Tax was 94383.25% (2022), while the steepest drop was 1100000.0% (2022).
  • Orthopediatrics' Profit After Tax (Quarter) stood at $72000.0 in 2021, then tumbled by 11000.0% to -$7.8 million in 2022, then rose by 14.74% to -$6.7 million in 2023, then tumbled by 140.16% to -$16.1 million in 2024, then grew by 26.73% to -$11.8 million in 2025.
  • Its Profit After Tax was -$11.8 million in Q3 2025, compared to -$7.1 million in Q2 2025 and -$10.7 million in Q1 2025.